Key result
TAVI evolves into standard care for high- and intermediate-risk AS.
Why the study?
This article outlines patient selection, pre-procedure evaluation, current perspectives, recent advances, current and future devices, guidelines, expanding indications, ongoing challenges, and the future of TAVI.
TAVI has revolutionized the management of aortic stenosis over the past two decades, expanding its indications across various risk profiles.
No takes yet. Share an insight, caveat, or question.
Supports TAVI adoption in aortic stenosis; leaves durability and low-risk expansion open for prospective study.
Naser Nabil (2023) conducted a review in Aortic stenosis. Transcatheter Aortic Valve Implantation (TAVI) was evaluated. Over 300,000 patients globally have received transcatheter aortic valve implantation, which has evolved into a standard of care for high- and intermediate-risk patients with aortic stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: